Skip to main content
SpringerLink
Log in

Peptic Ulcer Bleeding: Update on Standards from International Guidelines

  • Stomach (P Malfertheiner, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Abstract

Purpose of review

We review the latest advances in management of peptic ulcer bleeding and the updates from international guidelines.

Recent findings

A low Glasgow Blatchford score of ≤ 1 can safely identify low-risk patients to manage in out-patient settings. Except patients with persistent haemodynamic instability, early endoscopy within 24 h appears safe when compared with earlier intervention. Over-the-scope-clips (OTSC) show promising result as first-line and second-line endoscopic haemostaic therapy, while haemostatic spray can be considered as a stop-gap treatment. After endoscopic intervention, high-dose oral proton-pump-inhibitor (PPI) is an alternative to intravenous use in selected cases. Retrospective data shows new-generation P2Y12 inhibitors (prasugrel and ticagrelor) have higher risk of bleeding when compared with clopidogrel. Vonoprazan, a potassium-competitive acid blocker and a potent acid suppressor, shows encouraging initial results in management of gastrointestinal bleeding.

Summary

Endoscopic therapy remains the mainstay of treatment of peptic ulcer bleeding and future research will clarify the role of new endoscopic treatment modalities such as OTSC. Good peri-endoscopic treatment remains crucial, and more data is needed to guide management in patients on new generation anti-platelet drugs and direct oral anti-coagulants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Rosenstock SJ, Møller MH, Larsson H, Johnsen SP, Madsen AH, Bendix J, et al. Improving quality of care in peptic ulcer bleeding: nationwide cohort study of 13,498 consecutive patients in the Danish Clinical Register of Emergency Surgery. Am J Gastroenterol. 2013;108(9):1449–57.

    Article  PubMed  Google Scholar 

  2. •• Sung JJ, Chiu PW, Chan FKL, Lau JY, Goh KL, Ho LH, et al. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018. Gut. 2018;67(10):1757–68 One of the two large international guidelines updated in the past three years.

  3. Kwan I, Bunn F, Chinnock P, Roberts I. Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev. 2014;2014(3):CD002245.

    PubMed Central  Google Scholar 

  4. Laine L, Yang H, Chang SC, Datto C. Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009. Am J Gastroenterol. 2012;107(8):1190–5 quiz 1196.

  5. Abougergi MS, Travis AC, Saltzman JR. The in-hospital mortality rate for upper GI hemorrhage has decreased over 2 decades in the United States: a nationwide analysis. Gastrointest Endosc. 2015;81(4):882–8.e1.

    Article  PubMed  Google Scholar 

  6. Wuerth BA, Rockey DC. Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis. Dig Dis Sci. 2018;63(5):1286–93.

    Article  PubMed  Google Scholar 

  7. Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer. 2017;20(Suppl 1):3–7.

    Article  CAS  PubMed  Google Scholar 

  8. Zamani M, Ebrahimtabar F, Zamani V, Miller WH, Alizadeh-Navaei R, Shokri-Shirvani J, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868–76.

    Article  CAS  PubMed  Google Scholar 

  9. Fujishiro M, Iguchi M, Kakushima N, Kato M, Sakata Y, Hoteya S, et al. Guidelines for endoscopic management of non-variceal upper gastrointestinal bleeding. Dig Endosc. 2016;28(4):363–78.

    Article  PubMed  Google Scholar 

  10. Sung JJ, Tsoi KK, Ma TK, Yung MY, Lau JY, Chiu PW. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol. 2010;105(1):84–9.

    Article  PubMed  Google Scholar 

  11. •• Barkun AN, Almadi M, Kuipers EJ, Laine L, Sung J, Tse F, et al. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group. Ann Intern Med. 2019;171(11):805–22 One of the two large international guidelines updated in past three years.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Schreiber MA, Meier EN, Tisherman SA, Kerby JD, Newgard CD, Brasel K, et al. A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients: results of a prospective randomized pilot trial. J Trauma Acute Care Surg. 2015;78(4):687–95 discussion 695-7.

  13. Carrick MM, Morrison CA, Tapia NM, Leonard J, Suliburk JW, Norman MA, et al. Intraoperative hypotensive resuscitation for patients undergoing laparotomy or thoracotomy for trauma: early termination of a randomized prospective clinical trial. J Trauma Acute Care Surg. 2016;80(6):886–96.

    Article  PubMed  Google Scholar 

  14. Odutayo A, Desborough MJ, Trivella M, Stanley AJ, Dorée C, Collins GS, et al. Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials. Lancet Gastroenterol Hepatol. 2017;2(5):354–60.

    Article  PubMed  Google Scholar 

  15. Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg. 1986;73(10):783–5.

    Article  CAS  PubMed  Google Scholar 

  16. Restellini S, Kherad O, Jairath V, Martel M, Barkun AN. Red blood cell transfusion is associated with increased rebleeding in patients with nonvariceal upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2013;37(3):316–22.

    Article  CAS  PubMed  Google Scholar 

  17. Subramaniam K, Spilsbury K, Ayonrinde OT, Latchmiah F, Mukhtar SA, Semmens JB, et al. Red blood cell transfusion is associated with further bleeding and fresh-frozen plasma with mortality in nonvariceal upper gastrointestinal bleeding. Transfusion. 2016;56(4):816–26.

    Article  CAS  PubMed  Google Scholar 

  18. Laursen SB, Dalton HR, Murray IA, Michell N, Johnston MR, Schultz M, et al. Performance of new thresholds of the Glasgow Blatchford score in managing patients with upper gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2015;13(1):115–21.e2.

    Article  PubMed  Google Scholar 

  19. Ramaekers R, Mukarram M, Smith CA, Thiruganasambandamoorthy V. The predictive value of preendoscopic risk scores to predict adverse outcomes in emergency department patients with upper gastrointestinal bleeding: a systematic review. Acad Emerg Med. 2016;23(11):1218–27.

    Article  PubMed  Google Scholar 

  20. Gralnek IM, Ching JY, Maza I, Wu JC, Rainer TH, Israelit S, et al. Capsule endoscopy in acute upper gastrointestinal hemorrhage: a prospective cohort study. Endoscopy. 2013;45(1):12–9.

    CAS  PubMed  Google Scholar 

  21. Sung JJ, Tang RS, Ching JY, Rainer TH, Lau JY. Use of capsule endoscopy in the emergency department as a triage of patients with GI bleeding. Gastrointest Endosc. 2016;84(6):907–13.

    Article  PubMed  Google Scholar 

  22. Meltzer AC, Ward MJ, Gralnek IM, Pines JM. The cost-effectiveness analysis of video capsule endoscopy compared to other strategies to manage acute upper gastrointestinal hemorrhage in the ED. Am J Emerg Med. 2014;32(8):823–32.

    Article  PubMed  Google Scholar 

  23. Zakko L, Rustagi T, Douglas M, Laine L. No benefit from platelet transfusion for gastrointestinal bleeding in patients taking antiplatelet agents. Clin Gastroenterol Hepatol. 2017;15(1):46–52.

    Article  PubMed  Google Scholar 

  24. Nagata N, Sakurai T, Moriyasu S, Shimbo T, Okubo H, Watanabe K, et al. Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding. PLoS One. 2017;12(9):e0183423.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, et al. Andexanet Alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2016;375(12):1131–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gralnek IM, Dumonceau JM, Kuipers EJ, Lanas A, Sanders DS, Kurien M, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2015;47(10):a1–46.

    Article  PubMed  Google Scholar 

  27. Padhi S, Kemmis-Betty S, Rajesh S, Hill J, Murphy MF. Guideline Development Group. Blood transfusion: summary of NICE guidance. BMJ. 2015;351:h5832.

    Article  PubMed  Google Scholar 

  28. Daneshmend TK, Hawkey CJ, Langman MJ, Logan RF, Long RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ. 1992;304(6820):143–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hawkey GM, Cole AT, McIntyre AS, Long RG, Hawkey CJ. Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut. 2001;49(3):372–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Lau JY, Leung WK, Wu JC, Chan FK, Wong VW, Chiu PW, et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med. 2007;356(16):1631–40.

    Article  CAS  PubMed  Google Scholar 

  31. Sreedharan A, Martin J, Leontiadis GI, Dorward S, Howden CW, Forman D, et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010;2010(7):CD005415.

    PubMed Central  Google Scholar 

  32. Khuroo MS, Khuroo MS, Farahat KL, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. J Gastroenterol Hepatol. 2005;20(1):11–25.

    Article  CAS  PubMed  Google Scholar 

  33. Trial Collaborators HALT-IT. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10241):1927–36.

    Article  Google Scholar 

  34. • Lau JYW, Yu Y, Tang RSY, Chan HCH, Yip HC, Chan SM, et al. Timing of endoscopy for acute upper gastrointestinal bleeding. N Engl J Med. 2020;382(14):1299–308 Offers powerful evidence on optimal timing for endoscopy in AUGIB cases.

    Article  PubMed  Google Scholar 

  35. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol. 2009;7(1):33–47 quiz 1-2.

  36. Vergara M, Calvet X, Gisbert JP. Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers. Cochrane Database Syst Rev 2007 ;(2):CD005584.

  37. Nunoue T, Takenaka R, Hori K, Okazaki N, Hamada K, Baba Y, et al. A randomized trial of monopolar soft-mode coagulation versus heater probe thermocoagulation for peptic ulcer bleeding. J Clin Gastroenterol. 2015;49(6):472–6.

    Article  CAS  PubMed  Google Scholar 

  38. Yamasaki Y, Takenaka R, Nunoue T, Kono Y, Takemoto K, Taira A, et al. Monopolar soft-mode coagulation using hemostatic forceps for peptic ulcer bleeding. Hepatogastroenterology. 2014;61(136):2272–6.

    PubMed  Google Scholar 

  39. Kim JW, Jang JY, Lee CK, Shim JJ, Chang YW. Comparison of hemostatic forceps with soft coagulation versus argon plasma coagulation for bleeding peptic ulcer--a randomized trial. Endoscopy. 2015;47(8):680–7.

    Article  PubMed  Google Scholar 

  40. Chandrasekar VT, Desai M, Aziz M, Patel HK, Gorrepati VS, Jegadeesan R, et al. Efficacy and safety of over-the-scope clips for gastrointestinal bleeding: a systematic review and meta-analysis. Endoscopy. 2019;51(10):941–9.

    Article  PubMed  Google Scholar 

  41. • Schmidt A, Gölder S, Goetz M, Meining A, Lau J, von Delius S, et al. Over-the-scope clips are more effective than standard endoscopic therapy for patients with recurrent bleeding of peptic ulcers. Gastroenterology. 2018;155(3):674–686.e6 Provides important data on the efficacy of OTCS compared with other endoscopic haemostatic therapies.

    Article  PubMed  Google Scholar 

  42. Cox ED, Schreiber MA, McManus J, Wade CE, Holcomb JB. New hemostatic agents in the combat setting. Transfusion. 2009;49(Suppl 5):248S–55S.

    Article  PubMed  Google Scholar 

  43. Sung JJ, Luo D, Wu JC, Ching JY, Chan FK, Lau JY, et al. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy. 2011;43(4):291–5.

    Article  CAS  PubMed  Google Scholar 

  44. Smith LA, Stanley AJ, Bergman JJ, Kiesslich R, Hoffman A, Tjwa ET, et al. Hemospray application in nonvariceal upper gastrointestinal bleeding: results of the survey to evaluate the application of hemospray in the luminal tract. J Clin Gastroenterol. 2014;48(10):e89–92.

    Article  PubMed  Google Scholar 

  45. Sulz MC, Frei R, Meyenberger C, Bauerfeind P, Semadeni GM, Gubler C. Routine use of Hemospray for gastrointestinal bleeding: prospective two-center experience in Switzerland. Endoscopy. 2014;46(7):619–24.

    Article  PubMed  Google Scholar 

  46. Kwek BEA, Ang TL, Ong PLJ, Tan YLJ, Ang SWD, Law NM, et al. TC-325 versus the conventional combined technique for endoscopic treatment of peptic ulcers with high-risk bleeding stigmata: a randomized pilot study. J Dig Dis. 2017;18(6):323–9.

    Article  CAS  PubMed  Google Scholar 

  47. Jensen DM, Kovacs TOG, Ohning GV, Ghassemi K, Machicado GA, Dulai GS, et al. Doppler endoscopic probe monitoring of blood flow improves risk stratification and outcomes of patients with severe nonvariceal upper gastrointestinal hemorrhage. Gastroenterology. 2017;152(6):1310–1318.e1.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Troland D, Stanley A. Endotherapy of peptic ulcer bleeding. Gastrointest Endosc Clin N Am. 2018;28(3):277–89.

    Article  PubMed  Google Scholar 

  49. Lau JYW, Pittayanon R, Wong KT, Pinjaroen N, Chiu PWY, Rerknimitr R, et al. Prophylactic angiographic embolisation after endoscopic control of bleeding to high-risk peptic ulcers: a randomised controlled trial. Gut. 2019;68(5):796–803.

    Article  CAS  PubMed  Google Scholar 

  50. Kim HK, Kim JS, Kim TH, Kim CW, Cho YS, Kim SS, et al. Effect of high-dose oral rabeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. Gastroenterol Res Pract. 2012;2012:317125.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Yen HH, Yang CW, Su WW, Soon MS, Wu SS, Lin HJ. Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy. BMC Gastroenterol. 2012;12:66–230X -12-66.

  52. • Chan FKL, Goh KL, Reddy N, Fujimoto K, Ho KY, Hokimoto S, et al. Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines. Gut. 2018;67(3):405–17 An important summary about the peri-endoscopic use of antithrombotic agents.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010;152(1):1–9.

    Article  PubMed  Google Scholar 

  54. Qureshi W, Mittal C, Patsias I, Garikapati K, Kuchipudi A, Cheema G, et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol. 2014;113(4):662–8.

    Article  CAS  PubMed  Google Scholar 

  55. Witt DM, Delate T, Garcia DA, Clark NP, Hylek EM, Ageno W, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med. 2012;172(19):1484–91.

    Article  CAS  PubMed  Google Scholar 

  56. ASGE Standards of Practice Committee, Acosta RD, Abraham NS, Chandrasekhara V, Chathadi KV, Early DS, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016;83(1):3–16.

    Article  Google Scholar 

  57. Guo CG, Chen L, Chan EW, Cheung KS, Isshiki T, Wong ICK, et al. Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y(12) inhibitors compared with clopidogrel. Aliment Pharmacol Ther. 2019;49(1):7–19.

    Article  CAS  PubMed  Google Scholar 

  58. Ray S. Clopidogrel resistance: the way forward. Indian Heart J. 2014;66(5):530–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Marabotto E, Ziola S, Savarino V, Giannini EG, Furnari M, Bodini G, et al. Vonoprazan Fumarate for the treatment of gastric ulcers: a short review on emerging data. Clin Exp Gastroenterol. 2020;13:99–104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Miwa H, Uedo N, Watari J, Mori Y, Sakurai Y, Takanami Y, et al. Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials. Aliment Pharmacol Ther. 2017;45(2):240–52.

    Article  CAS  PubMed  Google Scholar 

  61. • Tsujita K, Deguchi H, Uda A, Sugano K. Upper gastrointestinal bleeding in Japanese patients with ischemic heart disease receiving vonoprazan or a proton pump inhibitor with multiple antithrombotic agents: A nationwide database study. J Cardiol. 2020;76(1):51–7 Offers rare large-scale data on the potential of vonoprazan in management of AUGIB.

    Article  PubMed  Google Scholar 

  62. Hamada K, Uedo N, Tonai Y, Arao M, Suzuki S, Iwatsubo T, et al. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study. J Gastroenterol. 2019;54(2):122–30.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institue of Digestive Disease and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

    Marc T. L. Wong MBBS, MRCP & Francis K. L. Chan MBBS, MRCP, FHKAM, FHKCP

Authors
  1. Marc T. L. Wong MBBS, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francis K. L. Chan MBBS, MRCP, FHKAM, FHKCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc T. L. Wong MBBS, MRCP.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Stomach

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wong, M.T.L., Chan, F.K.L. Peptic Ulcer Bleeding: Update on Standards from International Guidelines. Curr Treat Options Gastro 19, 80–93 (2021). https://doi.org/10.1007/s11938-020-00325-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-020-00325-8

Keywords

Search

Navigation